MoneyWorks4Me

Lupin informs about press release

11 Jul 2023 Evaluate
Lupin has informed that it enclosed a Press Release as regards, receipt of Establishment Inspection Report from the US FDA for the Company’s Pithampur Unit-2 manufacturing facility which manufactures oral solids and ophthalmic dosage forms. This is considered as a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..